knowledge -WSS

knowledge

author：focus 2025-08-23 18:39:04 - browse：2

Joaquin Duato -- health policy coverage from STAT — Johnson & Johnson CEO Joaquin Duato MICHAEL BUHOLZER/AFP via Getty Images

WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday.

The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries. Sanders had scheduled a vote to subpoena the Merck and Johnson & Johnson CEOs on Jan. 31, but canceled it on Friday.

“The use of a subpoena was clearly a last resort and I’m delighted that these CEOs will be coming into our committee voluntarily,” Sanders said in a written statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Problems with a popular proposal to regulate AI in health care

focus

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

AstraZeneca stays mum on Medicare drug pricing negotiations

Top private equity targets in 2023: cardiology, clinical trials, lasers

The Biogen Aduhelm mess could happen again

Problems with a popular proposal to regulate AI in health care

A controversial new treatment promises to make little people taller

hotspot

knowledge

Wikipedia

Sports medicine is finally prioritizing gender equality

The a glaring gap in research on serious mental illness and primary care

Hepatitis C has a cure — but many Americans still lack access to it

Heart disease in astronauts blamed on cosmic radiation

Activists slam private health insurers over coverage restrictions

A single Democrat is willing to weaken Medicare negotiation power

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

AI gets buy

Duchenne breakthrough therapy leaves behind pioneering families

Adopting new red light myopia treatments may be short

explore

Heart disease in astronauts blamed on cosmic radiation

Johnson & Johnson sued for allegedly overpaying for workers' drugs

CDC recommends RSV monoclonal antibody for infants

The cancer stories no one wants to hear

FDA approves Sage Therapeutics’ rapid

Why Novartis is going to walk from its acquisition of MorphoSys

focus

focus

leisure time

hotspot